




Healthcare News Roundup: Venture Capital
HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development